10x Genomics (NASDAQ:TXG) Now Covered by Guggenheim

Guggenheim began coverage on shares of 10x Genomics (NASDAQ:TXG – Free Report) in a report issued on Thursday morning, MarketBeat reports. The firm issued a buy rating and a $60.00 price objective on the stock. A number of other brokerages also recently commented on TXG. Wolfe Research initiated coverage on 10x Genomics in a research […]

Related Keywords

United States ,China ,Indiana ,America ,James Wilbur ,Serge Saxonov ,Asia Pacific ,Barclays ,Wolfe Research ,Comerica Bank ,Atlas Capital Advisors ,Canaccord Genuity Group ,Harvest Fund Management Co ,Genomics Inc ,Indiana Trust Investment Management ,Financial Services Group Inc ,Free Report ,Genuity Group ,Moderate Buy ,Genomics Trading Down ,Get Free Report ,Investment Management ,Fund Management ,Capital Advisors ,Services Group ,North America ,Middle East ,Genomics Daily ,10x Genomics ,Nasdaq Txg ,Ftxg ,Medical ,Initiated Coverage ,Guggenheim ,